Latest Peyronie's disease Stories
LYNBROOK, N.Y., Nov. 12, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
- Auxilium to exercise the exclusive option to expand the field of its license of CCH to include the potential treatment of canine lipoma LYNBROOK, N.Y., Nov.
LYNBROOK, N.Y., Nov. 3, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
Multiple Presentations Designed to Enable a Better Understanding of the Safety and Efficacy Profile of XIAFLEX for Treatment of Peyronie's Disease CHESTERBROOK, Pa., Nov.
- Label expansion to broaden patient base who may benefit from nonsurgical collagenase therapy LYNBROOK, N.Y., Oct.
Estimated 35-40 Percent of Surgical Procedures to Treat DC Have Been Performed on Multiple Joints CHESTERBROOK, Pa., Oct.
LYNBROOK, N.Y., Oct. 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
Erectile Dysfunction in Younger and Older Men Has Many Overlooked Causes. NEW YORK, Sept.
LYNBROOK, N.Y., Sept. 19, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp.
- Data suggest support for potential label expansion of XIAFLEX for Dupuytren's contracture to include treatment of two affected joints concurrently; PDUFA date is October 20, 2014 - LYNBROOK,
- An armed gangster.